181 related articles for article (PubMed ID: 20299819)
1. Gemcitabine induces the VMP1-mediated autophagy pathway to promote apoptotic death in human pancreatic cancer cells.
Pardo R; Lo Ré A; Archange C; Ropolo A; Papademetrio DL; Gonzalez CD; Alvarez EM; Iovanna JL; Vaccaro MI
Pancreatology; 2010; 10(1):19-26. PubMed ID: 20299819
[TBL] [Abstract][Full Text] [Related]
2. A Novel E2F1-EP300-VMP1 Pathway Mediates Gemcitabine-Induced Autophagy in Pancreatic Cancer Cells Carrying Oncogenic KRAS.
Ropolo A; Catrinacio C; Renna FJ; Boggio V; Orquera T; Gonzalez CD; Vaccaro MI
Front Endocrinol (Lausanne); 2020; 11():411. PubMed ID: 32655498
[TBL] [Abstract][Full Text] [Related]
3. PVT1 Knockdown Inhibits Autophagy and Improves Gemcitabine Sensitivity by Regulating the MiR-143/HIF-1α/VMP1 Axis in Pancreatic Cancer.
Liu YF; Luo D; Li X; Li ZQ; Yu X; Zhu HW
Pancreas; 2021 Feb; 50(2):227-234. PubMed ID: 33565800
[TBL] [Abstract][Full Text] [Related]
4. The role of autophagy in the treatment of pancreatic cancer with gemcitabine and ionizing radiation.
Mukubou H; Tsujimura T; Sasaki R; Ku Y
Int J Oncol; 2010 Oct; 37(4):821-8. PubMed ID: 20811703
[TBL] [Abstract][Full Text] [Related]
5. Gemcitabine-Induced Autophagy Protects Human Lung Cancer Cells from Apoptotic Death.
Wu HM; Shao LJ; Jiang ZF; Liu RY
Lung; 2016 Dec; 194(6):959-966. PubMed ID: 27604425
[TBL] [Abstract][Full Text] [Related]
6. Linc-ROR confers gemcitabine resistance to pancreatic cancer cells via inducing autophagy and modulating the miR-124/PTBP1/PKM2 axis.
Li C; Zhao Z; Zhou Z; Liu R
Cancer Chemother Pharmacol; 2016 Dec; 78(6):1199-1207. PubMed ID: 27785603
[TBL] [Abstract][Full Text] [Related]
7. The enhancement of Tetrandrine to gemcitabine-resistant PANC-1 cytochemical sensitivity involves the promotion of PI3K/Akt/mTOR-mediated apoptosis and AMPK-regulated autophagy.
Song J; Xu J; Guo J; Shang Y; Wang J; Wang T
Acta Histochem; 2021 Sep; 123(6):151769. PubMed ID: 34416437
[TBL] [Abstract][Full Text] [Related]
8. Gemcitabine induces apoptosis and autophagy via the AMPK/mTOR signaling pathway in pancreatic cancer cells.
Zhu J; Chen Y; Ji Y; Yu Y; Jin Y; Zhang X; Zhou J
Biotechnol Appl Biochem; 2018 Sep; 65(5):665-671. PubMed ID: 29575133
[TBL] [Abstract][Full Text] [Related]
9. The pancreatitis-induced vacuole membrane protein 1 triggers autophagy in mammalian cells.
Ropolo A; Grasso D; Pardo R; Sacchetti ML; Archange C; Lo Re A; Seux M; Nowak J; Gonzalez CD; Iovanna JL; Vaccaro MI
J Biol Chem; 2007 Dec; 282(51):37124-33. PubMed ID: 17940279
[TBL] [Abstract][Full Text] [Related]
10. Novel role of VMP1 as modifier of the pancreatic tumor cell response to chemotherapeutic drugs.
Gilabert M; Vaccaro MI; Fernandez-Zapico ME; Calvo EL; Turrini O; Secq V; Garcia S; Moutardier V; Lomberk G; Dusetti N; Urrutia R; Iovanna JL
J Cell Physiol; 2013 Sep; 228(9):1834-43. PubMed ID: 23460482
[TBL] [Abstract][Full Text] [Related]
11. Autophagy is needed for the growth of pancreatic adenocarcinoma and has a cytoprotective effect against anticancer drugs.
Hashimoto D; Bläuer M; Hirota M; Ikonen NH; Sand J; Laukkarinen J
Eur J Cancer; 2014 May; 50(7):1382-90. PubMed ID: 24503026
[TBL] [Abstract][Full Text] [Related]
12. Expression of heat shock protein 70 modulates the chemoresponsiveness of pancreatic cancer.
Hyun JJ; Lee HS; Keum B; Seo YS; Jeen YT; Chun HJ; Um SH; Kim CD
Gut Liver; 2013 Nov; 7(6):739-46. PubMed ID: 24312717
[TBL] [Abstract][Full Text] [Related]
13. Triptolide induces cell death in pancreatic cancer cells by apoptotic and autophagic pathways.
Mujumdar N; Mackenzie TN; Dudeja V; Chugh R; Antonoff MB; Borja-Cacho D; Sangwan V; Dawra R; Vickers SM; Saluja AK
Gastroenterology; 2010 Aug; 139(2):598-608. PubMed ID: 20434451
[TBL] [Abstract][Full Text] [Related]
14. The Antipancreatic Cancer Activity of OSI-027, a Potent and Selective Inhibitor of mTORC1 and mTORC2.
Chen B; Xu M; Zhang H; Xu MZ; Wang XJ; Tang QH; Tang JY
DNA Cell Biol; 2015 Oct; 34(10):610-7. PubMed ID: 26284306
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic potential of sepantronium bromide YM155 in gemcitabine-resistant human urothelial carcinoma cells.
Huang YT; Cheng CC; Lin TC; Chiu TH; Lai PC
Oncol Rep; 2014 Feb; 31(2):771-80. PubMed ID: 24297644
[TBL] [Abstract][Full Text] [Related]
16. Interplay between autophagy and apoptosis in pancreatic tumors in response to gemcitabine.
Papademetrio DL; Cavaliere V; Simunovich T; Costantino S; Campos MD; Lombardo T; Kaiser CM; Alvarez E
Target Oncol; 2014 Jun; 9(2):123-34. PubMed ID: 23588416
[TBL] [Abstract][Full Text] [Related]
17. Depletion of pro-oncogenic RUNX2 enhances gemcitabine (GEM) sensitivity of p53-mutated pancreatic cancer Panc-1 cells through the induction of pro-apoptotic TAp63.
Ozaki T; Nakamura M; Ogata T; Sang M; Yoda H; Hiraoka K; Sang M; Shimozato O
Oncotarget; 2016 Nov; 7(44):71937-71950. PubMed ID: 27713122
[TBL] [Abstract][Full Text] [Related]
18. Demethylzeylasteral (ZST93) inhibits cell growth and enhances cell chemosensitivity to gemcitabine in human pancreatic cancer cells via apoptotic and autophagic pathways.
Wang F; Tian X; Zhang Z; Ma Y; Xie X; Liang J; Yang C; Yang Y
Int J Cancer; 2018 May; 142(9):1938-1951. PubMed ID: 29238973
[TBL] [Abstract][Full Text] [Related]
19. Fisetin Enhances the Cytotoxicity of Gemcitabine by Down-regulating ERK-MYC in MiaPaca-2 Human Pancreatic Cancer Cells.
Kim N; Kang MJ; Lee SH; Son JH; Lee JE; Paik WH; Ryu JK; Kim YT
Anticancer Res; 2018 Jun; 38(6):3527-3533. PubMed ID: 29848706
[TBL] [Abstract][Full Text] [Related]
20. Chemoresistance is associated with increased cytoprotective autophagy and diminished apoptosis in bladder cancer cells treated with the BH3 mimetic (-)-Gossypol (AT-101).
Mani J; Vallo S; Rakel S; Antonietti P; Gessler F; Blaheta R; Bartsch G; Michaelis M; Cinatl J; Haferkamp A; Kögel D
BMC Cancer; 2015 Apr; 15():224. PubMed ID: 25885284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
